Skip to main content
Premium Trial:

Request an Annual Quote

Celera Makes Stem Cell Deal, Acquires Paracel, Reaches Mouse Milestone

Premium

ROCKVILLE, Md.--Celera is expected to announce at any moment that it has completed the human genome sequence. Instead, so far this month, it has announced a string of other achievements.

 

On June 1, Celera said that it had sequenced more than one billion base pairs of the mouse genome, which it began sequencing on April 6. The mouse sequence data is expected to be used in a human genome annotation jamboree that Celera will reportedly host in June or July.

 

Celera also announced that it established a deal with Geron, a company with expertise in human pluripotent stem cell biology, by which it will identify and determine the function of genes important in early human development. Celera will use data derived from the collaboration to enhance annotation of the human genome and develop and commercialize probe sets for gene expression analysis. Geron will develop and commercialize small molecule drugs and other products.

 

Celera also said it had closed its acquisition of Paracel, a genomic and text analysis supercomputing technology company. All equity of Paracel was exchanged for approximately 2.26 million shares of Celera stock.

Filed under

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.